|
2025
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central ner... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
2024
|
G/S
|
pharmaceutical preparations for veterinary use, namely, anti-inflammatories, insecticides, and ho... |
|
|
G/S
|
Pharmaceutical preparations for use in Oncology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
Invention
|
2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors.
Novel compounds of the structural formu... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Methods for treatment and prophylaxis of hiv and aids.
The present invention is directed to meth... |
|
|
Invention
|
Lyosphere critical reagent kit.
The present invention provides lyophilized pellets of low concen... |
|
|
Invention
|
Treatment of migraine.
The present disclosure provides methods for the acute treatment of migrai... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
Invention
|
Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protei... |
|
|
Invention
|
Formulations of antiviral compounds.
The present disclosure is directed to pharmaceutical formul... |
|
|
Invention
|
Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjug... |
|
|
Invention
|
Platform for analysis of high-throughput sequencing data.
A sequencing data analysis platform ca... |
|
|
Invention
|
A raman spectroscopy method for monitoring and feedback control of perfusion cell culture. The pr... |
|
|
Invention
|
Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death recep... |
|
|
Invention
|
Combination therapy of a pd-1 antagonist and lag3 antagonist for treating patients with cancer be... |
|
|
Invention
|
Methods to control polysorbate degradation in biotherapeutic formulations. The disclosure provide... |
|
|
Invention
|
Sustained-release formulations for poorly permeable cyclic peptides. The present disclosure provi... |
|
|
Invention
|
Inhibitors of human respiratory syncytial virus and metapneumovirus.
The present disclosure is d... |
|
|
Invention
|
Inhibitors of human respiratory syncytial virus and metapneumovirus. The present disclosure is di... |
|
|
Invention
|
Methods for detecting pcr chimeras. The present disclosure relates to methods for detecting PCR c... |
|
|
Invention
|
Lipolytic activity assay. Methods for rapidly measuring the level of active enzymes within an mAb... |
|
|
Invention
|
Multiproduct resin reuse (mrr) for the development and clinical manufacture of therapeutic protei... |
|
|
Invention
|
Monovalent interleukin 12 (il-12) heterodimeric fc proteins. Monovalent IL-12 heterodimeric Fc pr... |
|
|
Invention
|
Monovalent interleukin 12 (il-12) heterodimeric fc proteins.
Monovalent IL-12 heterodimeric Fc p... |
|
|
Invention
|
Anti-tigit antibodies.
The present invention relates to anti-TIGIT antibodies, as well as use of... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals; human vaccine preparations p... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
Invention
|
Solid dosage form of a small molecule antiviral and uses thereof. NRSRRHH)-yl]oxolan-2-yl}methyl ... |
|
|
Invention
|
Small molecule protein degraders of kras g12d mutant. Compounds disclosed herein or their pharmac... |
|
|
Invention
|
Small molecule protein degraders of kras g12d mutant. Compounds or their pharmaceutically accepta... |
|
|
Invention
|
Scalable chromatography process for purification of human cytomegalovirus.
The present invention... |
|
|
Invention
|
Spirocyclic wrn helicase inhibitors. The present disclosure is directed to compounds of Formula I... |
|
|
Invention
|
Tetrahydroquinazoline derivatives as selective cytotoxic agents.
The present disclosure is direc... |
|
|
Invention
|
Tetrahydroquinazoline derivatives as selective cytotoxic agents. The present disclosure is direct... |
|
|
Invention
|
Treatment combination, and use thereof and treatment method. The present invention relates to a t... |
|
|
Invention
|
Treatment method and use of pharmaceutical combination containing conjugate. The present inventio... |
|
|
Invention
|
Combination therapies for the treatment of cancer. Provided are methods of treating a cellular pr... |
|
|
Invention
|
Combination therapies for the treatment of non-small cell lung cancer. Provided are methods of tr... |
|
|
Invention
|
Processes for preparing soluble guanylate cyclase stimulators. The invention relates a processes ... |
|
|
Invention
|
Processes for preparing crystalline soluble guanylate cyclase stimulators. The invention relates ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of respiratory, gynecological, and neurological dis... |
|
2023
|
G/S
|
Providing medical information relating to cancer Personal support services for cancer patients, n... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
|
Invention
|
Plasma kallikrein inhibitors.
The present invention provides a compound of Formula (I) and pharm... |
|
2022
|
Invention
|
Substituted benzothiophene derivatives and methods of use thereof.
Provided are novel Substitute... |
|
|
Invention
|
Biomarkers for predicting eligibility for an anti-ilt4 and anti-pd-1 combination therapy.
Disclo... |
|
|
Invention
|
Pyrazolopyrimidine derivatives and methods of use thereof for the treatment of herpesviruses.
Pr... |
|
|
Invention
|
Antimalarial agents.
Provided are methods of treating malaria comprising administration of compo... |
|
|
Invention
|
P53 peptidomimetic macrocycles.
Disclosed are p53 peptidomimetic macrocycles, each p53 peptidomi... |
|
|
Invention
|
Blocking and non-blocking single domain antibodies and uses thereof.
The invention relates, in p... |
|
|
Invention
|
Fused pyrazole urea analogs as glucosylceramide synthase inhibitors.
The present invention relat... |
|
|
Invention
|
C-terminal extended p53 activator crosslinked peptidomimetic macrocycles against mdm2/mdmx.
The ... |
|
|
Invention
|
Chromane amidine monobactam antibiotics.
The present invention relates to monobactam compounds o... |
|
|
Invention
|
Modified short interfering nucleic acid (sina) molecules and uses thereof.
Disclosed herein are ... |
|
|
Invention
|
Methods for treating acute myeloid leukemia with anti-ilt3 antibodies.
This disclosure relates t... |
|
|
Invention
|
Methods for treating cancer using a combination of a pd-1 antagonist, an ilt4 antagonist, and che... |
|
|
Invention
|
Methods for treating cancer with subcutaneous administration of anti-pd1 antibodies.
The inventi... |
|
2021
|
Invention
|
Insulin receptor partial agonists.
Insulin dimers and insulin analog dimers that act as partial ... |
